Search results
Added:
2 years ago
Added:
3 years ago
Topic: 5. Secondary Prevention of Cardiovascular Disease.
Introduction
Coumadin therapy has been the best oral anticoagulation strategy available since several decades and is considered obligatory in some countries as the first strategy to be attempted because of economical reasons/arguments.
Objectives
To evaluate if patients already identified at highest-risk of stroke receive appropriate…
View more
Added:
3 years ago
Topic: 5. Secondary Prevention of Cardiovascular Disease.
Introduction and Objectives
Liaison critical pathways (LCPs) for coronary artery disease (CAD) were developed to support collaborative care for CAD patients between cardiologists in emergency hospitals and referring physicians through sharing of medical information, including cardio protective medications and cardiovascular risk…
View more
Added:
3 years ago
Coronary heart disease (CHD) is the leading cause of death in most countries. It is also a major cause of physical disability, particularly in the rapidly growing population of elderly people. The prevention of subsequent coronary events and the maintenance of physical functioning in such patients are major challenges in preventative care.
Cardiac rehabilitation (CR) programmes were first…
View more
Added:
3 years ago
Coronary heart disease (CHD) is the leading cause of death in most countries. It is also a major cause of physical disability, particularly in the rapidly growing population of elderly people. The prevention of subsequent coronary events and the maintenance of physical functioning in such patients are major challenges in preventative care.
Cardiac rehabilitation (CR) programmes were first…
View more
Added:
3 years ago
Stroke is the second most common cause of mortality worldwide.1 Cerebrovascular disease caused an estimated 5.7 million deaths in 2005, with 87% occurring in low- or middle-income countries.2 Without intervention, the global number of stroke deaths will rise to 6.5 million in 2015 and 7.8 million in 2030.2 Blood pressure is the most consistent and powerful predictor of stroke. Hypertension…
View more
Added:
3 years ago
As far as I know, the designation ‘optimal medical treatment’ was first used by the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial1 investigators as a synonym for the state-of-the-art measures encompassing drug regime, diet and physical activity recommended by the US guidelines for stable angina and acute coronary syndrome (ACS). Looking at the most…
View more
Added:
1 year ago
ESC Congress — Prof Marco Valgimigli (Cardiocentro Ticino Foundation, CH) shares the findings from an individual patient data meta-analysis from the PANTHER collaborative initiative that looked at P2Y12i or aspirin monotherapy as secondary prevention in patients with coronary artery disease.
The six randomised trials included in the study were CAPRIE, DACAB, TiCAB, GLASSY, CADET, STAMI. The aim…
View more
Added:
3 years ago
Left ventricular (LV) systolic dysfunction, defined by depressed LV ejection fraction (LVEF), has been recognised over the last two decades as the most robust parameter for identifying risk of sudden cardiac death (SCD). Specifically, LVEF has been a major determinant for entry into numerous randomised trials that aimed to investigate the efficacy of implantable cardioverter–defibrillators (ICDs)…
View more
Added:
11 months ago
